288 related articles for article (PubMed ID: 16836920)
1. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
Lu MQ; Cai CJ; Zhao H; Yang Y; Chen GH
Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):742-4. PubMed ID: 16836920
[TBL] [Abstract][Full Text] [Related]
2. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
[TBL] [Abstract][Full Text] [Related]
3. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
[TBL] [Abstract][Full Text] [Related]
4. [Lamivudine as prophylaxis against hepatitis B virus reinfection following orthotopic liver transplantation].
Zheng S; Wu J; Wang W; Huang D; Liang T; Lu A
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):445-8. PubMed ID: 12133511
[TBL] [Abstract][Full Text] [Related]
5. [Prevention and management of hepatitis B virus reinfection after liver transplantation].
Ma Y; Tai Q; He XS; Wang GD; Hu AB
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(16):1209-12. PubMed ID: 19781163
[TBL] [Abstract][Full Text] [Related]
6. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
[TBL] [Abstract][Full Text] [Related]
7. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
Woo HY; Choi JY; Jang JW; You CR; Bae SH; Yoon SK; Yang JM; Choi SW; Han NI; Kim DG
J Med Virol; 2008 Nov; 80(11):1891-9. PubMed ID: 18814257
[TBL] [Abstract][Full Text] [Related]
8. Dynamic alteration of HBV markers on active HBV replicative recipients after liver transplantation: a preliminary report.
Lu SC; Yan LN; Li B; Ma YK; Liu C; Wen TF; Lin QY; Zhao JC; Wang XB; Li XD; Qing S; Zhao LS; Liu C; Liu J; Zhang XH
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):196-201. PubMed ID: 14599968
[TBL] [Abstract][Full Text] [Related]
9. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.
Lo CM; Liu CL; Chan SC; Lau GK; Fan ST
J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658
[TBL] [Abstract][Full Text] [Related]
10. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P
Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584
[TBL] [Abstract][Full Text] [Related]
11. Prevention of hepatitis B virus reinfection after orthotopic liver transplantation.
Wang ZX; Ding GS; Fu H; Zhang JJ; Chen XS; Guo WY; Shi XM; Fu ZR
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):345-8. PubMed ID: 15313666
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
[TBL] [Abstract][Full Text] [Related]
13. Advances in prophylaxis and treatment of recurrent hepatitis B after liver transplantation.
Wang ZF; Zhu ZJ; Shen ZY
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):509-14. PubMed ID: 16286253
[TBL] [Abstract][Full Text] [Related]
14. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
15. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the changes of HBV serum markers and HBV DNA and the effects of perioperative factors after liver transplantation].
Tang YM; Chen GH; He XS; Zhu XF; Chen MH
Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):164-7. PubMed ID: 15760545
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of hepatitis B virus recurrence after liver transplantation.
Han YS; Lee SK; Joh JW; Kim SJ; Kwon CH; Park JW; Kim DJ; Park JB
Transplant Proc; 2006 Sep; 38(7):2123-4. PubMed ID: 16980019
[TBL] [Abstract][Full Text] [Related]
18. Changes in serological markers of hepatitis B virus after renal transplantation.
Urbini Dos Santos C; Sevá-Pereira T; Alves-Filho G; Lorena SL; Soares EC; Mazzali M
Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006
[TBL] [Abstract][Full Text] [Related]
19. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation in European patients with the hepatitis B surface antigen.
Samuel D; Muller R; Alexander G; Fassati L; Ducot B; Benhamou JP; Bismuth H
N Engl J Med; 1993 Dec; 329(25):1842-7. PubMed ID: 8247035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]